🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the makers of Tylenol, asserting the companies withheld safety concerns that the medication created to children's cognitive development.

The court filing comes four weeks after Donald Trump advocated an unsubstantiated connection between using acetaminophen - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is suing J&J, which once produced the medication, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a declaration, he stated they "deceived the public by gaining financially from pain and pushing pills ignoring the risks."

The company says there is insufficient reliable data tying Tylenol to autism.

"These corporations lied for decades, intentionally threatening numerous people to line their pockets," Paxton, from the Republican party, stated.

Kenvue said in a statement that it was "very worried by the spread of false claims on the safety of paracetamol and the likely effects that could have on the welfare of US mothers and children."

On its website, the company also stated it had "regularly reviewed the relevant science and there is lacking reliable evidence that indicates a established connection between consuming paracetamol and autism."

Organizations acting on behalf of medical professionals and healthcare providers agree.

The leading OB-GYN organization has said acetaminophen - the primary component in acetaminophen - is one of the few options for pregnant women to address discomfort and elevated temperature, which can pose serious health risks if ignored.

"In more than two decades of investigation on the consumption of paracetamol in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any trimester of gestation results in neurodevelopmental disorders in offspring," the organization commented.

The court filing cites recent announcements from the former administration in asserting the drug is reportedly hazardous.

Recently, the former president caused concern from medical authorities when he told women during pregnancy to "fight like hell" not to consume acetaminophen when sick.

The FDA then released a statement that physicians should think about restricting the usage of Tylenol, while also declaring that "a proven link" between the medication and autism in young ones has not been established.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had pledged in spring to undertake "comprehensive study program" that would establish the origin of autism spectrum disorder in a limited time.

But experts advised that identifying a unique factor of autism - thought by researchers to be the outcome of a intricate combination of genetic and external influences - would prove challenging.

Autism is a form of permanent neurological difference and disability that impacts how individuals perceive and engage with the surroundings, and is recognized using physician assessments.

In his legal document, Paxton - a Trump ally who is running for federal office - asserts Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the evidence" around acetaminophen and autism.

This legal action seeks to make the corporations "destroy any marketing or advertising" that asserts Tylenol is secure for women during pregnancy.

The court case echoes the complaints of a group of parents of children with autism and ADHD who filed suit against the manufacturers of acetaminophen in two years ago.

Judicial authorities dismissed the legal action, saying research from the parents' expert witnesses was not conclusive.